- Treatment of chronic hepatitis C: Efficacy of initial treatment of peginterferon alpha-2a versus peginterferon alpha-2b plus ribavirin in naive chronic hepatitis C patients
-
Lee YJ
- KMID: 1073296
- Korean J Hepatol.
- 2008 Dec;14(4):443-445.
- doi: 10.3350/kjhep.2008.14.4.443
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of pegylated interferon and ribavirin in Korean patients with chronic hepatitis C virus infection
-
Kang MJ, Jung EU, Park SW, Choi P, Kim JH, Park SJ, Park ET, Lee YJ, Lee SH, Seol SY
- KMID: 1381462
- Korean J Hepatol.
- 2008 Sep;14(3):318-330.
- doi: 10.3350/kjhep.2008.14.3.318
BACKGROUND/AIMS: We assessed the efficacy and safety of pegylated interferon (peginterferon) plus ribavirin and identified the predictors of a sustained virologic response (SVR) in Korean patients with chronic hepatitis... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of therapeutic results between combination therapy of peginterferon alpha-2a plus ribavirin and interferon alpha-2b plus ribavirin according to treatment duration in patients with chronic hepatitis C
-
Lee HJ, Eun JR, Choi JW, Kim KO, Moon HJ
- KMID: 1073329
- Korean J Hepatol.
- 2008 Mar;14(1):46-57.
- doi: 10.3350/kjhep.2008.14.1.46
BACKGROUND/AIMS: This study compared the efficacy and safety of combined peginterferon alfa (PEG-IFN) and ribavirin with that of combined interferon alpha (IFN-alpha) and ribavirin, according to the treatment duration... -
- CITED
-
- Close
- SHARE
-
- Close
- 24 Weeks Treatment with Pegylated Interferon Alfa Plus Ribavirin May Be Possible in Genotype 1 Chronic Hepatitis C Patients with Rapid Virological Response Who Have Low Pretreatment Viremia
-
Moon SS, Kang HG, Seo JA, Jung EU, Lee SH, Park SJ, Lee YJ, Seol SY
- KMID: 1775876
- Korean J Gastroenterol.
- 2010 Jul;56(1):33-38.
- doi: 10.4166/kjg.2010.56.1.33
BACKGROUND/AIMS: The standard treatment for chronic hepatitis C infected with hepatitis C virus (HCV) genotype 1 is a combination of pegylated interferon alfa and ribavirin over a 48 weeks period.... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment with pegylated interferon and ribavirin in a patient with fibrosing cholestatic hepatitis due to recurrent hepatitis C after liver transplantation
-
Kim BK, Kwon SY, Ko SY, Choe WH, Lee CH, Han HS, Chang SH
- KMID: 1073304
- Korean J Hepatol.
- 2008 Dec;14(4):519-524.
- doi: 10.3350/kjhep.2008.14.4.519
Fibrosing cholestatic hepatitis (FCH) is the most devastating manifestation of recurrent hepatitis C in transplant recipients with hepatitis C virus (HCV), possibly leading to death or retransplantation. Although FCH was... -
- CITED
-
- Close
- SHARE
-
- Close
- Short-term Therapy with Pegylated Interferon plus Ribavirin for the Chronic Hepatitis C Genotype 2 Patients
-
Jung EU, Park JH, Pae KI, Kang SW, Park SJ, Jee SR, Park ET, Lee YJ, Lee SH, Seol SY
- KMID: 760735
- Korean J Hepatol.
- 2007 Sep;13(3):341-348.
- doi: 10.3350/kjhep.2007.13.3.341
BACKGROUND/AIMS: The standard treatment for chronic hepatitis C patients infected with HCV genotype-2 is a combination of pegylated interferon alfa and ribavirin over a 24 week period. It is... -
- CITED
-
- Close
- SHARE
-
- Close
- Assessment of the Efficacy of Reducing Peginterferon Alfa-2a and Ribavirin Dose on Virologic Response in Koreans with Chronic Hepatitis C
-
Kwon JH, Bae SH, Choi JY, Yoon SK, Byun KS, Paik SW, Lim YS, Lee HC, Han KH, Lee KS
- KMID: 1717943
- Korean J Intern Med.
- 2009 Sep;24(3):203-211.
- doi: 10.3904/kjim.2009.24.3.203
BACKGROUND/AIMS: The virologic response of Koreans to combination therapy for chronic hepatitis C is similar to westerns; however, dose modification occurs more frequently in Koreans. We evaluated the rates of... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of initial treatment with peginterferon alpha-2a versus peginterferon alpha-2b in combination with ribavirin in naive chronic hepatitis C patients living in Daejeon and Chungcheong Province in Korea: A comparative study
-
Kim JI, Kim SH, Lee BS, Lee HY, Lee TH, Kang YW, Lee HI, Kim AN, Nam SW, Park BC, Chae HB, Kim SB, Song IH, Park JY, Kim HS
- KMID: 1073301
- Korean J Hepatol.
- 2008 Dec;14(4):493-502.
- doi: 10.3350/kjhep.2008.14.4.493
BACKGROUNDS/AIMS: Peginterferon alpha-2a or -2b is the standard treatment regimen in chronic hepatitis C. However, there have been few comparative studies of the efficacies of these two types of... -
- CITED
-
- Close
- SHARE
-
- Close
- Peginterferon Alfa-2a plus Ribavirin for Initial Treatment of Chronic Hepatitis C in Korea
-
Lee H, Choi MS, Paik SW, Kim JH, Kim DY, Lee JH, Koh KC, Yoo BC, Rhee JC, Song SM
- KMID: 760628
- Korean J Hepatol.
- 2006 Mar;12(1):31-40.
BACKGROUND/AIMS: Combination therapy with peginterferon and ribavirin is a standard therapy for western patients with chronic hepatitis C; however, its efficacy remains unclear in East Asian patients. We evaluated... -
- CITED
-
- Close
- SHARE
-
- Close
- A comparison of 24- vs. 48-week peginterferon plus ribavirin in patients with genotype 1 chronic hepatitis C
-
Kim MN, Yoon KT, Park JY, Kim DY, Ahn SH, Chon CY, Han KH
- KMID: 1384057
- Korean J Hepatol.
- 2009 Dec;15(4):496-503.
- doi: 10.3350/kjhep.2009.15.4.496
BACKGROUND/AIMS: The standard therapy for patients with genotype 1 chronic hepatitis C (CHC) is a combination of peginterferon and ribavirin for 48 weeks. However, the most appropriate duration of treatment... -
- CITED
-
- Close
- SHARE
-
- Close
